Analysis of the effect of oral nutritional supplement or branched chain amino acid (BCAA) on liver cirrhotic patients with less than 3.5 g/dl of serum albumin level.
Not Applicable
- Conditions
- iver cirrhosis
- Registration Number
- JPRN-UMIN000011183
- Lead Sponsor
- Kanazawa Medical University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Not provided
Exclusion Criteria
1.Patients who are taking branched chain amino acid or oral nutritional supplement for liver failure. 2.Patients treated with albumin preparation. 3.Patients with refractory ascites. 4.Patients with history of hypersensitive against drugs. 5.Patients with liver cancer. 6.Patient with serious complications such as renal failure. 7.Patients who are heavy drinker more than 5 years. 8.Patient with refractory diabetes mellitus. 9.Patients who are pregnant or breastfeeding. 10.Patients whom cannot be obtained a written informed consent. 11.Patients judged to be inappropriate for the study by the investigator.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method